CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Optimi Health Corp is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Optimi Health Corp
Unit 600, 21 Water Street
Phone: (604) 377-0403p:604 377-0403 VANCOUVER, BC  V6B 1A1  Canada Ticker: OPTIOPTI
Business Summary
Optimi Health Corp. is an end-to-end drug researcher and formulator licensed by Health Canada to produce and supply, for clinical research purposes, psychedelic substances, such as 3,4-Methylenedioxymethamphetamine (MDMA), natural Manufacturing Practices (GMP)-grade psilocybin, as well as functional mushrooms that focus on the health and wellness markets. The Company produces scalable psychedelic formulations for transformational human experiences. Its products are grown and manufactured at its two facilities comprising a total of 20,000 square feet in Princeton, British Columbia. It is a supplier of drug and nutraceutical products. The Company works with customers, health food distributors, and drug developers, and patients regulated by Health Canada.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/20249/30/2023Yes----

Industries
SIC Code Description
2833 Medicinal chemicals and botanical products
0182 Food crops grown under cover
5499 Miscellaneous food stores

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Chairman of the Board James J.Wilson 33 7/6/2020 7/6/2020
Interim Chief Executive Officer, Director DaneStevens 33 10/21/2024 7/6/2020
Chief Financial Officer, Director JacobSafarik 35 8/25/2022 7/6/2020
Chief Operating Officer, Director BryanSafarik 38 7/6/2020 7/6/2020
Independent Director JonathanSchintler 44 10/7/2020 10/7/2020

Business Names
Business Name
8BN
OPTI

General Information
Number of Employees: 9 (As of 9/30/2021)
Outstanding Shares: 94,663,356 (As of 9/9/2024)
Stock Exchange: CNQ


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, December 3, 2024